All schedule II-V controlled substances listed in Minnesota Statutes Sect. 152.02 are required to be reported to the MN PMP.
This list includes additional prescriptions that are scheduled in Minnesota, and not currently federally scheduled such as human growth hormone, pseudoephedrine (reported only when dispensed according to a prescription), and chorionic gonadotropin.
Minnesota has also identified drugs of concern that are required to be reported to the MN PMP. These are gabapentin and all formulations of butalbital.